BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 11474113)

  • 1. Lysophosphatidylcholine as a ligand for the immunoregulatory receptor G2A.
    Kabarowski JH; Zhu K; Le LQ; Witte ON; Xu Y
    Science; 2001 Jul; 293(5530):702-5. PubMed ID: 11474113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunology. The push-me pull-you of T cell activation.
    Carson MJ; Lo D
    Science; 2001 Jul; 293(5530):618-9. PubMed ID: 11474091
    [No Abstract]   [Full Text] [Related]  

  • 3. T cell chemotaxis to lysophosphatidylcholine through the G2A receptor.
    Radu CG; Yang LV; Riedinger M; Au M; Witte ON
    Proc Natl Acad Sci U S A; 2004 Jan; 101(1):245-50. PubMed ID: 14681556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sphingosylphosphorylcholine and lysophosphatidylcholine are ligands for the G protein-coupled receptor GPR4.
    Zhu K; Baudhuin LM; Hong G; Williams FS; Cristina KL; Kabarowski JH; Witte ON; Xu Y
    J Biol Chem; 2001 Nov; 276(44):41325-35. PubMed ID: 11535583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sphingosylphosphorylcholine is a ligand for ovarian cancer G-protein-coupled receptor 1.
    Xu Y; Zhu K; Hong G; Wu W; Baudhuin LM; Xiao Y; Damron DS
    Nat Cell Biol; 2000 May; 2(5):261-7. PubMed ID: 10806476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The G protein-coupled receptor GPR4 suppresses ERK activation in a ligand-independent manner.
    Bektas M; Barak LS; Jolly PS; Liu H; Lynch KR; Lacana E; Suhr KB; Milstien S; Spiegel S
    Biochemistry; 2003 Oct; 42(42):12181-91. PubMed ID: 14567679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Previously postulated "ligand-independent" signaling of GPR4 is mediated through proton-sensing mechanisms.
    Tobo M; Tomura H; Mogi C; Wang JQ; Liu JP; Komachi M; Damirin A; Kimura T; Murata N; Kurose H; Sato K; Okajima F
    Cell Signal; 2007 Aug; 19(8):1745-53. PubMed ID: 17462861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple actions of lysophosphatidylcholine in human Jurkat T cells.
    Im YJ; Lee YK; Chung HY; Im DS
    Acta Pharmacol Sin; 2006 Jun; 27(6):700-7. PubMed ID: 16723088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. G2A is a proton-sensing G-protein-coupled receptor antagonized by lysophosphatidylcholine.
    Murakami N; Yokomizo T; Okuno T; Shimizu T
    J Biol Chem; 2004 Oct; 279(41):42484-91. PubMed ID: 15280385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sphingosylphosphorylcholine stimulates human monocyte-derived dendritic cell chemotaxis.
    Lee HY; Shin EH; Bae YS
    Acta Pharmacol Sin; 2006 Oct; 27(10):1359-66. PubMed ID: 17007744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of the lysophosphatidylcholine effector, G2A, ameliorates aortic atherosclerosis in low-density lipoprotein receptor knockout mice.
    Parks BW; Lusis AJ; Kabarowski JH
    Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2703-9. PubMed ID: 16990555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysophosphatidylcholine as a ligand for immunoregulation.
    Kabarowski JH; Xu Y; Witte ON
    Biochem Pharmacol; 2002 Jul; 64(2):161-7. PubMed ID: 12123735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysophosphatidylcholine up-regulates CXCR4 chemokine receptor expression in human CD4 T cells.
    Han KH; Hong KH; Ko J; Rhee KS; Hong MK; Kim JJ; Kim YH; Park SJ
    J Leukoc Biol; 2004 Jul; 76(1):195-202. PubMed ID: 15178707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two ligands for a GPCR, proton vs lysolipid.
    Im DS
    Acta Pharmacol Sin; 2005 Dec; 26(12):1435-41. PubMed ID: 16297340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EDG1 receptor stimulation leads to cardiac hypertrophy in rat neonatal myocytes.
    Robert P; Tsui P; Laville MP; Livi GP; Sarau HM; Bril A; Berrebi-Bertrand I
    J Mol Cell Cardiol; 2001 Sep; 33(9):1589-606. PubMed ID: 11549339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of lysophosphatidylcholine on transmembrane signal transduction.
    Prokazova NV; Zvezdina ND; Korotaeva AA
    Biochemistry (Mosc); 1998 Jan; 63(1):31-7. PubMed ID: 9526092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gi-independent macrophage chemotaxis to lysophosphatidylcholine via the immunoregulatory GPCR G2A.
    Yang LV; Radu CG; Wang L; Riedinger M; Witte ON
    Blood; 2005 Feb; 105(3):1127-34. PubMed ID: 15383458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sphingosylphosphorylcholine and lysophosphatidylcholine: G protein-coupled receptors and receptor-mediated signal transduction.
    Xu Y
    Biochim Biophys Acta; 2002 May; 1582(1-3):81-8. PubMed ID: 12069813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the role of sphingosine 1-phosphate and its receptors in high-density lipoprotein-induced stimulation of astroglial cell function.
    Malchinkhuu E; Sato K; Muraki T; Ishikawa K; Kuwabara A; Okajima F
    Biochem J; 2003 Mar; 370(Pt 3):817-27. PubMed ID: 12470300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of G2A, a receptor for lysophosphatidylcholine, by macrophages in murine, rabbit, and human atherosclerotic plaques.
    Rikitake Y; Hirata K; Yamashita T; Iwai K; Kobayashi S; Itoh H; Ozaki M; Ejiri J; Shiomi M; Inoue N; Kawashima S; Yokoyama M
    Arterioscler Thromb Vasc Biol; 2002 Dec; 22(12):2049-53. PubMed ID: 12482833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.